Name | Type | Posted | Actions |
|---|---|---|---|
12639526Q0082 Amendment 1.pdf | May 14, 2026 |
Foot and Mouth Disease Virus (FMDV) Enzyme Linked Immunosorbent Assay (ELISA) Kits
Contact and place of performance
Kathy Melby
Ames, IA 50010
USA
The purpose of this amendment is to:
1. Edit the Statement of Requirements specifications second bulleted item to add “at time of award" (highlighted in yellow) to now read "Must be Center for Veterinary Biologics (CVB) licensed/permitted at time of award",
2. Incorporate the mandatory contract clause FAR 52.222.90, Addressing DEI Discrimination by Federal Contractors, as required by Executive Order 14398 (highlighted in yellow), and
3. Extend quote due date to 3:00pm ET 5/15/26.
The United States Department of Agriculture, Animal and Plant Health Inspection Service (APHIS) is seeking Foot and Mouth Disease Virus (FMDV) Enzyme Linked Immunosorbent Assay (ELISA) Kits. This special notice, issued under solicitation number 12639526Q0082A0001, requires that all kits be Center for Veterinary Biologics (CVB) licensed or permitted at the time of award. The acquisition falls under NAICS code 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. There is no set-aside designated for this requirement.
Performance is located in Ames, Iowa, and falls under the oversight of the APHIS Management and Regulatory Polices Business Services. Current updates to the solicitation include the incorporation of mandatory contract clause FAR 52.222.90 regarding DEI discrimination and an extension of the submission schedule. Quotations are due by 3:00 p.m. ET on May 15, 2026. One attachment, an amendment document, was published with the notice on May 14, 2026. Kathy Melby serves as the primary point of contact for this procurement.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.